Last reviewed · How we verify
NCT05097651
CBD for Sleep in People With HIV
Phase 2 trial testing Cannabidiol oral solution in Sleep Disturbance. Withdrawn.
31 August 2023
Quick facts
| Lead sponsor | Mariana Cherner, PhD |
|---|---|
| Phase | Phase 2 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Start date | 1 April 2021 |
| Primary completion | 31 August 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cannabidiol oral solution — full drug profile →
- Inert sesame seed oil — full drug profile →
Conditions studied
- Sleep Disturbance — all drugs for Sleep Disturbance →
Sponsor
Mariana Cherner, PhD — full company profile →
Who can join
18 and older, any sex, with Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will obtain preliminary information about whether, and at what dose, cannabidiol (CBD) may help with insomnia in people living with human immunodeficiency virus (HIV). The study will be a 5-week randomized, double-blind placebo-controlled phase II trial using daily oral CBD doses between 50mg and 600mg. Sleep problems will be measured using a wrist-worn device and by self-report. Performance on tests of thinking skills will be compared before and after CBD/placebo treatment. Positive study results will provide support for the use of CBD as a potential treatment for insomnia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The therapeutic potential of purified cannabidiol.
O'Sullivan SE, Jensen SS, Nikolajsen GN, Bruun HZ, et al · · 2023 · cited 33× · PMID 37312194 · DOI 10.1186/s42238-023-00186-9
Verify or expand the search:
- PubMed search for NCT05097651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cannabidiol oral solution
Trials testing the same drug.
- NCT05885542 — SCORE Emerging Adult Cannabis Use & Stress · Phase 1, PHASE2 · recruiting
- NCT05803434 — Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy · Phase 2 · unknown
- NCT05600114 — Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder · Phase 2 · completed
- NCT03196934 — Expanded Use of Cannabidiol Oral Solution · no longer available
Other recruiting trials for Sleep Disturbance
Currently open trials in the same condition.
- NCT07503223 — Sleep Optimization With Acoustic Therapy · NA · recruiting
- NCT07464626 — Virtual vs Physical Art Therapy for Anxiety, Psychological Well-being, and Sleep Quality in Colorectal Cancer Patients · NA · recruiting
- NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
- NCT07354776 — Effect of Isometric Neck Exercises on Cervicogenic Headache, Cortisol, and BDNF in Adolescents With Smartphone Addiction · NA · recruiting
- NCT07119268 — SPARK Healthy Sleep · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05097651 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mariana Cherner, PhD
- Last refreshed: 10 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05097651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing